Evolent Health Announces First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
- Oil prices little changed as Saudi cuts prices, OPEC+ boosts target
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Dara Khosrowshahi steps down from Grab Holdings board
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
Evolent Health (EVH) Tops Q1 EPS by 6c
May 9, 2018 4:38 PM EDTEvolent Health (NYSE: EVH) reported Q1 EPS of $0.02, $0.06 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $144.4 million versus the consensus estimate of $140.6 million.
Business Outlook
For the full year 2018, Adjusted Revenue is expected to be in the range of... More
